Fact Meets Function

Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury.

Researchers developed an injectable hydrogel system combining GHK-Cu with carbon dots to treat radiation-induced skin injuries. The smart delivery system releases antioxidants first to combat oxidative stress, then releases GHK-Cu in a sustained manner to promote tissue repair and collagen formation. In vitro and in vivo testing showed the combination effectively accelerated healing of radiation-damaged skin by addressing both the inflammatory and regenerative phases of wound healing. This represents a novel dual-phase approach using GHK-Cu for clinical wound management.

Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury. Read Post »

Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury.

Researchers developed an injectable hydrogel system combining GHK-Cu with carbon dots to treat radiation-induced skin injuries. The smart delivery system releases antioxidants first to combat oxidative stress, then releases GHK-Cu in a sustained manner to promote tissue repair and collagen formation. In vitro and in vivo testing showed the combination effectively accelerated healing of radiation-damaged skin by addressing both the inflammatory and regenerative phases of wound healing. This represents a novel dual-phase approach using GHK-Cu for clinical wound management.

Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury. Read Post »

Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway.

This research demonstrates that thymosin beta-4 (TB4) significantly reduces sepsis-associated acute kidney injury in mice by suppressing the MAPK signaling pathway, which drives inflammatory responses and cell death. The study shows TB4 administration after LPS exposure restored kidney function, reduced inflammation markers (IL-6, IL-1β, IL-18), and prevented apoptosis. The mechanism was validated through transcriptome sequencing and confirmed that TB4 blocks phosphorylation of JNK1/2, p38 MAPK, and ERK1/2. This positions TB4 as a potential early intervention therapy for a high-mortality sepsis complication affecting critically ill patients.

Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway. Read Post »

D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer’s disease.

For your business Preclinical data suggest D-chiro-inositol may support brain insulin signaling and reduce amyloid load; worth monitoring for translational

D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer’s disease. Read Post »

SIRT1 deacetylates PKM2 to constrain lactate production and protect against premature ovarian insufficiency.

Researchers identified that SIRT1 deacetylation of PKM2 suppresses lactate production in ovarian granulosa cells, and that SIRT1 downregulation drives premature ovarian insufficiency (POI). Both AAV-SIRT1 gene therapy and systemic NMN administration reversed POI phenotypes in a cisplatin mouse model and corrected hormonal markers. This establishes NAD+-boosting interventions like NMN as a novel therapeutic pathway for POI, a condition affecting ovarian function and fertility.

SIRT1 deacetylates PKM2 to constrain lactate production and protect against premature ovarian insufficiency. Read Post »

The impact of nicotinamide mononucleotide on ovarian health: A comprehensive literature review of preclinical evidence and therapeutic potential.

This comprehensive literature review synthesizes preclinical evidence showing NMN improves ovarian health through NAD+ restoration, enhancing mitochondrial function, reducing oxidative stress, and modulating sirtuin activity. Animal studies demonstrate NMN delays ovarian aging, improves oocyte quality, restores hormonal profiles, and shows promise in chemotherapy-induced and age-related ovarian decline. The review identifies significant therapeutic potential for reproductive conditions including premature ovarian insufficiency and PCOS, while highlighting the critical gap between strong animal data and the lack of human clinical trials needed for clinical translation.

The impact of nicotinamide mononucleotide on ovarian health: A comprehensive literature review of preclinical evidence and therapeutic potential. Read Post »

Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.

Researchers successfully incorporated BPC-157 into a chitosan-based hydrogel matrix, achieving 98.9% encapsulation with 81.2% release within 24 hours. The composite demonstrated strong antibacterial properties against E. coli and S. aureus, good biocompatibility, and injectability—suggesting practical delivery advantages for practitioners. This advancement demonstrates viable formulation strategies for peptide stability and bioavailability, relevant to oral and topical delivery optimization.

Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel. Read Post »

Administration of Methylene Blue to Facilitate the Management of Post-Cardiac Arrest Refractory Shock.

This case report explores methylene blue as a potential treatment for post-cardiac arrest refractory shock, a condition with over 50% mortality and few evidence-based options. While methylene blue has shown promise in post-operative cardiac bypass settings, its use in cardiac arrest outside surgery remains largely unstudied. The case suggests methylene blue may warrant clinical investigation as a therapeutic option for practitioners managing critically ill post-arrest patients.

Administration of Methylene Blue to Facilitate the Management of Post-Cardiac Arrest Refractory Shock. Read Post »

Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway.

This PLoS One study demonstrates that methylene blue combined with vitamin B12 effectively alleviates experimental septic shock by modulating specific cellular pathways (KCNMB1 and cGMP-PRKG), addressing circulatory failure and microvascular dysfunction. The research validates a synergistic mechanism between two compounds often used separately in vasodilatory shock management. For practitioners, this finding supports the rationale for combined MB+VB12 protocols in critical care and suggests potential applications beyond sepsis in other conditions involving vascular dysfunction and metabolic dysregulation.

Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway. Read Post »

Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.

This real-world comparative effectiveness study evaluates methylene blue and high-dose hydroxocobalamin as adjunctive vasodilator therapies in septic shock patients when standard treatments fail. The research uses a large multicenter electronic health record network to compare hemodynamic outcomes between these two compounds. For practitioners using peptide and compound-based protocols, this data provides evidence on an emerging supportive therapy class that may complement standard sepsis management.

Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX. Read Post »

Nicotinamide Mononucleotide Ameliorates Myocardial Fibrosis in Diabetic Mice Possibly by Modulating SIRT3 to Deacetylate GSK3β and Thereby Reducing the Phosphorylation of Smad3.

This animal study demonstrates that NMN ameliorates type 2 diabetes-induced myocardial fibrosis in mice through upregulation of SIRT3, which deacetylates GSK3β and suppresses Smad3 phosphorylation—key drivers of cardiac fibrosis. The research shows NMN reversed elevated fibrosis markers (collagen I, α-SMA) and improved cardiac function and structure in diabetic mice. This mechanistic work supports NMN’s therapeutic potential as an intervention for diabetes-related cardiac complications, a significant comorbidity concern for practitioners.

Nicotinamide Mononucleotide Ameliorates Myocardial Fibrosis in Diabetic Mice Possibly by Modulating SIRT3 to Deacetylate GSK3β and Thereby Reducing the Phosphorylation of Smad3. Read Post »

Shopping Cart
Scroll to Top